Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis

By sjmartinez • April 5, 2023

Kugelmas M, Loftus M, Owen EJ, Wadei H, Saab S. Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis. Am J Health Syst Pharm. 2023 Apr 4:zxad070. doi: 10.1093/ajhp/zxad070. Epub ahead of print. PMID: 37013893.

Tags: albumin, ascites, Cirrhosis, Digestive Diseases, hepatorenal syndrome, Publications, spontaneous bacterial peritonitis, terlipressin

The ULK1-NCOA3 axis restrains de novo lipogenesis and prevents diet-induced steatohepatitis and fibrosis in mice

Koo YD, Castillo RT, Sukumaran Nair A, Garneau M, Gochee C, Campbell ZV, Vakil TS, Ha J, Marti A, Soto J, Das D, Martinez-Lopez N,[...]

The management of hepatorenal syndrome-acute kidney injury (HRS-AKI): A national survey of hepatology provider practices

Cullaro G, Im GY, Chandna S, Lee BT, Simonetto DA, Aby ES, Izzy M, Gonzalez SA, Sherman CB, Aron J, Luther J, Goel A, Jophlin[...]

Disparities in Healthcare Seeking and Physician Diagnosis of Irritable Bowel Syndrome: Results from a US Survey

Almario CV, Liu J, Higgins C, Yerneni N, Boules M, Chey WD, Chang L. Disparities in Healthcare Seeking and Physician Diagnosis of Irritable Bowel Syndrome:[...]